28 October 2020
Freemasons New Zealand have renewed their support of the Institute’s CAR T-cell programme, pledging a further $600,000 over the next three years.
Freemasons New Zealand Grand Master Graham Wrigley says Freemasons New Zealand are proud to continue to support the Institute’s work because it is practical research that will have real outcomes that have the potential to improve the lives of all New Zealanders.
“Freemasons New Zealand donate extensively to medical research programmes like this CAR T-cell research because they are a promising and effective way that we can do something tangible to help New Zealanders. Our support is motivated by the guiding principles that underpin Freemasonry, particularly compassion and love of, and support for, humankind.”
Director of the Malaghan Institute professor Graham Le Gros says the financial partnership with the Freemasons provides a significant and vital boost to the Institute’s CAR T-cell research.
“As an independent research organisation and charity, the Malaghan Institute relies on support from the community and the generosity of organisations like Freemasons whose support, along with that of other organisations, will allow us to accelerate the availability of this ground-breaking treatment in New Zealand.”
Improving CAR T-cell therapy to target solid tumours
23 May 2022
International Day of Immunology 2022: Vaccine research enters a new era with mRNA technology
29 April 2022
Our Changing World - the future of cancer treatment
31 March 2022
In focus: How ancient relationships can provide solutions to cancer therapy
17 March 2022
In focus: Overcoming hurdles facing CAR T-cell therapy
19 January 2022
New study opens doors for immunotherapies for prostate cancer
13 December 2021